Effect of SynagisⓇ (palivizumab) prophylaxis on readmission due to respiratory syncytial virus in very low birth weight infants

Purpose : The aim of this study was to determine the efficacy of Synagis&amp&#59;#9415&#59; (palivizumab) in reducing the respiratory syncytial virus (RSV) readmission rate in very low birth weight infants (VLBWI ) and the subgroup that showed the most effective vaccination....

Full description

Bibliographic Details
Main Authors: Soo Kyoung Park, Yu Jin Jung, Hye Soo Yoo, So Yoon Ahn, Hyun Joo Seo, Seo Heui Choi, Myo Jing Kim, Ga Won Jeon, Soo Hyun Koo, Kyung-Hoon Lee, Yun Sil Chang, Won Soon Park
Format: Article
Language:English
Published: Korean Pediatric Society 2010-03-01
Series:Korean Journal of Pediatrics
Online Access:http://www.kjp.or.kr/upload/2010530312-20100434155234.PDF